Read + Share
Ning S, Armstrong CM, Xing E, Leslie AR, et al. LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance
in Advanced Prostate Cancer. Cancer Res 2024 Aug 1. doi: 10.1158/0008-5472.CAN-24-0440.
PMID: 39088701
|
 |
|
Ning S, Armstrong CM, Xing E, Leslie AR, et al. LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance
in Advanced Prostate Cancer. Cancer Res 2024 Aug 1. doi: 10.1158/0008-5472.CAN-24-0440.
PMID: 39088701
|
|
|
|